The effect of thyroid hormone therapy on angiographic coronary artery disease progression

Canadian Journal of Cardiology

Volumn 13, Issue 3, 1997, Pages 273-276

  Perk, Masis ^a   O'Neill, Blair J ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Atherosclerosis; Hypothyroidism; Thyroid hormones

Indexed keywords

THYROID HORMONE; THYROXINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CANADA; CLINICAL ARTICLE; COHORT ANALYSIS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MALE; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

AGED; CORONARY DISEASE; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROXINE;

EID: 0031005876     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Garnero P, Gineyts E, Riou JP, Delmas PD Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab 1994;79:780-4.
2. Ayala J, Rodriguez M, Jimenez JM, Mendez A, Blanco A. Occurrence and evolution of T3 fibroblast nuclei in healing tendons from growing chicks. Scand J Plast Reconstr Hand Surg 1991;25:217-20.
3. Kinlaw WB III. Atherosclerosis and the thyroid. Thyroid Today 1991;14:1-8.
4. Steinberg AD. Myxedema and coronary artery disease - a comparative autopsy study. Ann Intern Med 1968;68:338-43.
5. Van Haelst L, Neve P, Chailly P, Bastenie PA. Coronary artery disease in hypothyroidism. Observations in clinical myxedema. Lancet 1967;ii:800.
6. Bydlowski SP, Stivaletti VLG, Douglas CR. Effects of mast cell inhibition on plasma and aortic content of lipids, hexosamine and hydroxyproline in rats. Role of thyroid gland. Gen Pharmacol 1986;17:247-50.
7. Jocelyn JJ, Ladenson PW. Subclinical thyroid dysfunction in the elderly. Thyroid Today 1994;5:79-86.
8. Levine HD. Compromise therapy in the patient with angina pectoris and hypothyroidism A clinical assessment. Am J Med 1980;69:411-8.
9. Thibault GE. Clinical interaction of hypothyroidism and coronary artery disease.Thyrotd Today. 1991;14:2-4.
10. Comtois R, Lemay C, Laliberté A. Coexistence of hypothyroidism and myocardial infarction. Can J Cardiol 1995;11:37-42.
11. Scheiffele E, Schultze KW. The Coronary Drug Project. JAMA 1972;221:918. (Lett)
12. Barnes BO. The Coronary Drug Project. JAMA 1972;221:918. (Lett)
13. Young WF, Gorman CA, Jiang N-S, Machacek D, Hay ID. L-thyroxine contamination of pharmaceutical D-thyroxine: Probable cause of therapeutic effect. Clin Pharmacol Ther 1984;36:781-7.
14. Best MM, Duncan H. Comparative effects of thyroxin analogues as hypocholesterolemic agents. Circulation 1961;24:58-67.
15. Gorman CA, Jiang N-S, Ellefson RD, Elveback LR. Comparative effectiveness of dextrothyroxine and levothyroxine in correcting hypothyroidism and lowering blood lipid levels in hypothyroid patients. J Clin Endocrinol Metab 1979;49:1-7.
16. Bantle JP, Oppenheimer JH, Schwartz HL, Hunninghake DB, Probsrfield JL, Hanson RF. TSH response to TRH in euthyroid, hypercholesterolemic patients treated with graded doses of dextrothyroxine. Metabolism 1981;30:63-6.
17. Bantle JP, Hunninghake DB, Frantz ID, et al Comparison of effectiveness of thyrotropin suppressive doses of D- and L-thyroxine in treatment of hypercholesterolemia. Am J Med 1984;77:475-81.
18. The coronary drug project research group. The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. JAMA 1972;220:996-1008.
19. Waller BF. Pathology of new interventional procedures in coronary artery disease. Cardiol Clin 1988;18:63-75.
20. Barth JD, Jansen H, Kromhout D, Reiber JHC, Birkenhager JG, Anntzenius AC. Progression and regression of human coronary atherosclerosis. The role of lipoproteins, lipases and thyroid hormones in coronary lesion growth. Atherosclerosis 1987;68:51-8.